Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical ModelsVincenzo Quagliariello, Nicola Maurea, Margherita Passariello et al.|Journal of Personalized Medicine|2020Cited by 68
Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome ExpressionVincenzo Quagliariello, Nicola Maurea, Massimiliano Berretta et al.|Frontiers in Oncology|2021Cited by 45
PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in CardioncologyVincenzo Quagliariello, Nicola Maurea, Irma Bisceglia et al.|Cancers|2023Cited by 42
Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with COVID-19.Vincenzo Quagliariello, Nicola Maurea, Andrea Paccone et al.|PubMed|2021Cited by 30
SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer PatientsVincenzo Quagliariello, Nicola Maurea, Annamaria Bonelli et al.|Cancers|2020Cited by 28